Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy

NCT05206942 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05206942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05206942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Suspended
Start date
March 21, 2022
Completion date
September 28, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor